1
|
Vick LV, Yoon D, Perks JR, Li JJ, Murphy WJ, Monjazeb AM. Tumor Resistance to Fractionated Radiotherapy in Obese Mice. Int J Radiat Oncol Biol Phys 2023; 117:S139. [PMID: 37784355 DOI: 10.1016/j.ijrobp.2023.06.546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Obesity has reached pandemic levels in the United States and will soon surpass smoking as the number one cause of preventable cancer. Clinical data demonstrate that obese cancer patients are more resistant to radiotherapy and have higher rates of recurrence. Although a growing number of cancer patients are obese, and obesity is linked to poor outcomes with radiotherapy, little is understood about how obesity impacts the efficacy of radiotherapy. Understanding if and how obesity induces radio-resistance and how to best treat obese cancer patients is a critical unmet need. In this study we test the hypothesis that tumors in obese mice have increased resistance to fractionated radiotherapy. MATERIALS/METHODS Control and diet induce obese (DIO) mice were generated by feeding 4-6-week-old, genetically identical, inbred C57BL/6 mice with a high-fat diet consisting of 60% kcal from fat (DIO) or a control diet consisting of 10% fat (control) until 6 months of age. Mice were then implanted with syngeneic B16F0 tumors in the hind leg. When tumors reached 5mm in diameter mice were treated with fractionated radiotherapy (12 Gy delivered in daily 4 Gy fractions X 3 days) using a 2cm electron cutout to treat the tumor + margin only. RESULTS DIO mice had significantly increased body weight (control 30-40 g; DIO 50-65 g), significantly increased visceral and subcutaneous fat deposits, and elevated leptin levels. Blood glucose levels and HgbA1c in DIO mice, although slighter higher than controls, were within normal limits and did not indicate insulin resistance. Mice were divided into four groups of 8 mice (control, control + RT, DIO, DIO + RT). Fractionated radiotherapy (4 Gy x 3) significantly reduced the growth of B16F0 tumors by about three-fold in control mice compared to untreated controls. Radiotherapy failed to significantly reduce tumor size in DIO mice (compared to unirradiated DIO), although the treated tumors trended towards being modestly smaller. Additionally, tumors in the DIO + RT group were significantly larger than the tumors in the control + RT group. Initial mechanistic studies suggest increased tumor proliferation and immune dysfunction in DIO mice may induce the observed radio-resistance. CONCLUSION Using genetically identical mice with genetically identical tumors we demonstrate, for the first time, that diet and obesity can drastically alter the anti-tumor effects of radiotherapy. Mechanistic studies and studies in other tumor models are underway. Understanding how obesity impacts radiotherapy response and developing strategies to address these issues will improve outcomes in obese patients. Thus, these studies can have a major clinical impact and represent a step towards personalized medicine by tailoring radiotherapy treatment strategies to a patient's metabolic parameters.
Collapse
Affiliation(s)
| | | | - J R Perks
- University of California Davis, Sacramento, CA
| | - J J Li
- Department of Radiation Oncology, University of California Davis, Sacramento, CA
| | - W J Murphy
- University of California Davis, Sacramento, CA
| | - A M Monjazeb
- University of California Davis Comprehensive Cancer Center, Sacramento, CA
| |
Collapse
|
2
|
Kim JE, Kim EY, Oh S, Lee M, Yoon D, Min HJ, Choi HS, Kim YG, Chang EJ. POS0451 DEFICIENCY OF PPM1A IN MACROPHAGE AGGRAVATES PRISTANE-INDUCED LUPUS-LIKE DISEASE. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundProtein phosphatase Mg2+/Mn2+-dependent 1A (PPM1A) is a phosphatase which regulates various intracellular cell signaling pathways including inflammation. We previously suggested that the inflammatory signal decreased the PPM1A protein level in macrophage and this reduction had correlation with the chronic inflammatory bone disease, implying the possible role of PPM1A in inflammatory responses of macrophage.ObjectivesIn this study, we aim to elucidate the potential role of PPM1A in macrophage to regulate inflammatory response during the disease progression of systemic lupus erythematosus.MethodsWe generated macrophage-specific conditional gene-knockout (PPM1Afl/fl;LysM-Cre) mice and developed a lupus-like disease with immune complex glomerulonephritis in these PPM1Afl/fl;LysM-Cre mice by intraperitoneal pristane injection. Mouse serum was collected every 4 weeks after pristane injection. Serum anti-dsDNA IgG, anti-ssDNA IgG, interleukin-17 (IL-17) and tumor necrosis factor-α (TNF-α) was quantified by ELISA. After 41 weeks from pristane injection, histological changes in the kidney, spleen, and lung tissues were observed. To analyze M1/M2 polarization in vitro, LysM-Cre and PPM1Afl/fl;LysM-Cre mouse bone marrow-derived macrophages were cultured with lipopolysaccharide (LPS)/interferon-γ (IFN-γ) or interleukin-4 (IL-4) to check M1 or M2 related genes.ResultsWe found that macrophages of PPM1Afl/fl;LysM-Cre mice displayed different gene expression with LPS stimulation especially in M1/M2 related genes through the RNA-seq analysis and showed a decrease in both M1 and M2 polarization induced by LPS/IFN-γ or IL-4 stimulation. Notably, we found that PPM1Afl/fl;LysM-Cre mice with pristane injection showed a significant increase of anti-ssDNA IgG compared to LysM-Cre mice. PPM1Afl/fl;LysM-Cre mice showed severe lupus-like phenotypes such as global glomerular enlargement indicated by endocapillary proliferation and glomerular cellularity in kidney and lung inflammation accompanied by fibrosis, compared to LysM-Cre mouse by pristane injection. Together, serum IL-17 and TNF-α, which are proinflammatory cytokines, were increased in PPM1Afl/fl;LysM-Cre after pristane injection. These results indicate that PPM1A depletion in macrophage deteriorates inflammation and contributes to the tissue damage in a lupus-like disease.ConclusionOur findings suggest that the deficiency of PPM1A in macrophages impairs M1/M2 macrophage polarization leading to an immune imbalance in lupus-like disease model, providing a potential link between the loss of function of PPM1A in macrophages and its molecular target for treatment of systemic lupus erythematosus.References[1]Kwon, O. C., Choi, B., Lee, E. J., Park, J. E., Lee, E. J., Kim, E. Y., Kim, S. M., Shin, M. K., Kim, T. H., Hong, S., Lee, C. K., Yoo, B., Robinson, W. H., Kim, Y. G., & Chang, E. J. (2020). Negative Regulation of Osteoclast Commitment by Intracellular Protein Phosphatase Magnesium-Dependent 1A. Arthritis & rheumatology (Hoboken, N.J.), 72(5), 750–760. https://doi.org/10.1002/art.41180[2]Smith, S. R., Schaaf, K., Rajabalee, N., Wagner, F., Duverger, A., Kutsch, O., & Sun, J. (2018). The phosphatase PPM1A controls monocyte-to-macrophage differentiation. Scientific reports, 8(1), 902. https://doi.org/10.1038/s41598-017-18832-7Disclosure of InterestsNone declared.
Collapse
|
3
|
Yim J, Son N, Kim K, Yoon D, Cho Y, Lee S, Park Y, Kim K, Lee J, Kim J. W054 Suggestion of cystatin C indication using muscle mass-based parameter for the desirable prediction of glomerular filtration rate. Clin Chim Acta 2022. [DOI: 10.1016/j.cca.2022.04.185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
4
|
Hossain M, Park DS, Rahman MS, Ki SJ, Lee YR, Imran KM, Yoon D, Heo J, Lee TJ, Kim YS. Bifidobacterium longum DS0956 and Lactobacillus rhamnosus DS0508 culture-supernatant ameliorate obesity by inducing thermogenesis in obese-mice. Benef Microbes 2020; 11:361-373. [PMID: 32755263 DOI: 10.3920/bm2019.0179] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Excessive body fat and the related dysmetabolic diseases affect both developed and developing countries. The aim of this study was to investigate the beneficial role of a bacterial culture supernatant (hereafter: BS) of Lactobacillus and Bifidobacterium and their potential mechanisms of action on white-fat browning and lipolysis. For selection of four candidates among 55 Lactic acid producing bacteria (LAB) from human infant faeces, we evaluated by Oil Red O staining and Ucp1 mRNA quantitation in 3T3-L1 preadipocytes. The expression of browning and lipolysis markers was examined along with in vitro assays. The possible mechanism was revealed by molecular and biological experiments including inhibitor and small interfering RNA (siRNA) assays. In a mouse model, physiological, histological, and biochemical parameters and expression of some thermogenesis-related genes were compared among six experimental groups fed a high-fat diet and one normal-diet control group. The results allow us to speculate that BS treatment promotes browning and lipolysis both in vitro and in vivo. Moreover, the BS may activate thermogenic programs via a mechanism involving PKA-CREB signaling in 3T3-L1 cells. According to our data, we can propose that two LAB strains, Bifidobacterium longum DS0956 and Lactobacillus rhamnosus DS0508, may be good candidates for a dietary supplement against obesity and metabolic diseases; however, further research is required for the development as dietary supplements or drugs.
Collapse
Affiliation(s)
- M Hossain
- Institute of Tissue Regeneration, College of Medicine, Soonchunhyang University, Cheonan Chung-nam 31151, Republic of Korea.,Department of Microbiology, College of Medicine, Soonchunhyang University, Soonchunhyang 6 gil 31, Dongnam-Gu, Cheonan Chung-nam 31151, Republic of Korea
| | - D-S Park
- Biological Resource Center, Korea Research Institute of Bioscience and Biotechnology, 181 Ipsin-gil, Jeongeup-si, Jeollabuk-do 580-185, Republic of Korea
| | - M S Rahman
- Institute of Tissue Regeneration, College of Medicine, Soonchunhyang University, Cheonan Chung-nam 31151, Republic of Korea.,Department of Microbiology, College of Medicine, Soonchunhyang University, Soonchunhyang 6 gil 31, Dongnam-Gu, Cheonan Chung-nam 31151, Republic of Korea
| | - S-J Ki
- Biological Resource Center, Korea Research Institute of Bioscience and Biotechnology, 181 Ipsin-gil, Jeongeup-si, Jeollabuk-do 580-185, Republic of Korea
| | - Y R Lee
- Biological Resource Center, Korea Research Institute of Bioscience and Biotechnology, 181 Ipsin-gil, Jeongeup-si, Jeollabuk-do 580-185, Republic of Korea
| | - K M Imran
- Institute of Tissue Regeneration, College of Medicine, Soonchunhyang University, Cheonan Chung-nam 31151, Republic of Korea.,Department of Microbiology, College of Medicine, Soonchunhyang University, Soonchunhyang 6 gil 31, Dongnam-Gu, Cheonan Chung-nam 31151, Republic of Korea
| | - D Yoon
- Institute of Tissue Regeneration, College of Medicine, Soonchunhyang University, Cheonan Chung-nam 31151, Republic of Korea.,Department of Microbiology, College of Medicine, Soonchunhyang University, Soonchunhyang 6 gil 31, Dongnam-Gu, Cheonan Chung-nam 31151, Republic of Korea
| | - J Heo
- International Agricultural Development and Cooperation Center, Chonbuk National University, Jeonju 54896, Republic of Korea
| | - T-J Lee
- Department of Anatomy, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea
| | - Y-S Kim
- Institute of Tissue Regeneration, College of Medicine, Soonchunhyang University, Cheonan Chung-nam 31151, Republic of Korea.,Department of Microbiology, College of Medicine, Soonchunhyang University, Soonchunhyang 6 gil 31, Dongnam-Gu, Cheonan Chung-nam 31151, Republic of Korea
| |
Collapse
|
5
|
Bauml J, Yoon D, Yan P, Katz S, Jeffries S, Davis C, Aggarwal C, Cohen R, Marmarelis M, Singh A, Ciunci C, Wherry E, Albelda S, Langer C, Huang A. P2.04-02 Effect of Chemotherapy, Chemoimmunotherapy, and Immunotherapy on Parameters of T Cell Exhaustion in Metastatic Non-Small Cell Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
6
|
Kim S, Jo J, Yoon D, Hong J, Do Y, Yea J, Lim S, Shin H, Lee H, Yhim H, Yi J, Choi Y, Kim M, Yang D, Lee W, Kang H, Suh C, Kim W. RANDOMIZED PHASE II STUDY OF CHOP VS. FRACTIONATED ICED IN TRANSPLANT-ELIGIBLE PATIENTS WITH PREVIOUSLY UNTREATED PERIPHERAL T-CELL LYMPHOMA: INTERIM RESULTS OF CISL1504. Hematol Oncol 2019. [DOI: 10.1002/hon.146_2631] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- S. Kim
- Medicine; Samsung Medical Cneter; Seoul Republic of Korea
| | - J. Jo
- Internal Medicine; Ulsan University Hospital; Ulsan Republic of Korea
| | - D. Yoon
- Oncology; Asan Medical Center; Seoul Republic of Korea
| | - J. Hong
- Oncology; Asan Medical Center; Seoul Republic of Korea
| | - Y. Do
- Internal Medicine; Dongsan Medical Center; Daegu Republic of Korea
| | - J. Yea
- Radiation oncology; Yeungnam University Medical Center; Daegu Republic of Korea
| | - S. Lim
- Internal Medicine; Inje University College of Medicine, Haeundae Paik Hospital; Busan Republic of Korea
| | - H. Shin
- Internal Medicine; Pusan National University Hospital; Busan Republic of Korea
| | - H. Lee
- Internal Medicine; Konkuk University Medical Center; Seoul Republic of Korea
| | - H. Yhim
- Medicine; Chonbuk National University Medical School; Jeonju Republic of Korea
| | - J. Yi
- Internal Medicine; Chung-Ang University Hospital; Seoul Republic of Korea
| | - Y. Choi
- Internal Medicine; Chungnam National University; Daejon Republic of Korea
| | - M. Kim
- Internal Medicine; Yeungnam University College of Medicine; Daegu Republic of Korea
| | - D. Yang
- Internal Medicine; Chonnam National University Hwasun Hospital; Hwasun Republic of Korea
| | - W. Lee
- Internal Medicine; Inje University Busan Hospital; Busan Republic of Korea
| | - H. Kang
- Internal Medicine; Korea Cancer Center Hospital; Seoul Republic of Korea
| | - C. Suh
- Oncology; Asan Medical Center; Seoul Republic of Korea
| | - W. Kim
- Medicine; Samsung Medical Cneter; Seoul Republic of Korea
| |
Collapse
|
7
|
Rosi M, Levi ST, Pistolesi M, Bertagnini A, Brunelli D, Cannavò V, Di Renzoni A, Ferranti F, Renzulli A, Yoon D. Geoarchaeological Evidence of Middle-Age Tsunamis at Stromboli and Consequences for the Tsunami Hazard in the Southern Tyrrhenian Sea. Sci Rep 2019; 9:677. [PMID: 30679656 PMCID: PMC6346119 DOI: 10.1038/s41598-018-37050-3] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2018] [Accepted: 11/29/2018] [Indexed: 11/30/2022] Open
Abstract
Large-scale landslides at volcanic islands are one of the most dangerous geological phenomena, able to generate tsunamis whose effects can propagate far from the source. However, related deposits are scarcely preserved on-land in the geologic records, and are often difficult to be interpreted. Here we show the discovery of three unprecedented well-preserved tsunami deposits related to repeated flank collapses of the volcanic island of Stromboli (Southern Italy) occurred during the Late Middle Ages. Based on carbon datings, on stratigraphic, volcanological and archaeological evidence, we link the oldest, highest-magnitude investigated tsunami to the following rapid abandonment of the island which was inhabited at that time, contrary than previously thought. The destructive power of this event is also possibly related to a huge marine storm that devastated the ports of Naples in 1343 (200 km north of Stromboli) described by the famous writer Petrarch. The portrayed devastation can be potentially attributed to the arrival of multiple tsunami waves generated by a major landslide in Stromboli island, confirming the hypothetical hazard of these phenomena at a regional scale.
Collapse
Affiliation(s)
- M Rosi
- Dipartimento di Scienze della Terra, Università di Pisa, Pisa, Italy.
| | - S T Levi
- Dipartimento di Scienze Chimiche e Geologiche, Università di Modena e Reggio Emilia, Modena, Italy. .,Department of Classical and Oriental Studies, Hunter College, City University of New York, New York, USA.
| | - M Pistolesi
- Dipartimento di Scienze della Terra, Università di Pisa, Pisa, Italy
| | - A Bertagnini
- Istituto Nazionale di Geofisica e Vulcanologia, Pisa, Italy
| | - D Brunelli
- Dipartimento di Scienze Chimiche e Geologiche, Università di Modena e Reggio Emilia, Modena, Italy
| | - V Cannavò
- Dipartimento di Scienze Chimiche e Geologiche, Università di Modena e Reggio Emilia, Modena, Italy
| | - A Di Renzoni
- Istituto di Studi sul Mediterraneo Antico-CNR, Rome, Italy
| | - F Ferranti
- Associazione Preistoria Attuale, Bardonecchia, Torino, Italy
| | - A Renzulli
- Dipartimento di Scienze Pure e Applicate, Università di Urbino, Urbino, Italy
| | - D Yoon
- American Numismatic Society, New York, USA
| |
Collapse
|
8
|
Vennemann T, Jeong M, Yoon D, Magrez A, Berger H, Yang L, Živković I, Babkevich P, Rønnow HM. Note: Commercial SQUID magnetometer-compatible NMR probe and its application for studying a quantum magnet. Rev Sci Instrum 2018; 89:046101. [PMID: 29716319 DOI: 10.1063/1.5023675] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
We present a compact nuclear magnetic resonance (NMR) probe which is compatible with a magnet of a commercial superconducting quantum interference device magnetometer and demonstrate its application to the study of a quantum magnet. We employ trimmer chip capacitors to construct an NMR tank circuit for low temperature measurements. Using a magnetic insulator MoOPO4 with S = 1/2 (Mo5+) as an example, we show that the T-dependence of the circuit is weak enough to allow the ligand-ion NMR study of magnetic systems. Our 31P NMR results are compatible with previous bulk susceptibility and neutron scattering experiments and furthermore reveal unconventional spin dynamics.
Collapse
Affiliation(s)
- T Vennemann
- Laboratory for Quantum Magnetism, Institute of Physics, Ecole Polytechnique Féderale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - M Jeong
- Laboratory for Quantum Magnetism, Institute of Physics, Ecole Polytechnique Féderale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - D Yoon
- Laboratory of the Physics of Nanostructured Materials, Institute of Physics, Ecole Polytechnique Féderale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - A Magrez
- Crystal Growth Facility, Institute of Physics, Ecole Polytechnique Féderale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - H Berger
- Crystal Growth Facility, Institute of Physics, Ecole Polytechnique Féderale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - L Yang
- Laboratory for Quantum Magnetism, Institute of Physics, Ecole Polytechnique Féderale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - I Živković
- Laboratory for Quantum Magnetism, Institute of Physics, Ecole Polytechnique Féderale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - P Babkevich
- Laboratory for Quantum Magnetism, Institute of Physics, Ecole Polytechnique Féderale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - H M Rønnow
- Laboratory for Quantum Magnetism, Institute of Physics, Ecole Polytechnique Féderale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| |
Collapse
|
9
|
Mishra A, Nam GH, Gim JA, Lee HE, Jo A, Yoon D, Oh S, Kim S, Kim A, Kim DH, Kim YC, Jeong HD, Cha HJ, Choi YH, Kim HS. Comparative evaluation of MCP gene in worldwide strains of Megalocytivirus (Iridoviridae family) for early diagnostic marker. J Fish Dis 2018; 41:105-116. [PMID: 28914452 DOI: 10.1111/jfd.12685] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/04/2017] [Revised: 06/18/2017] [Accepted: 06/19/2017] [Indexed: 06/07/2023]
Abstract
Members of the Iridoviridae family have been considered as aetiological agents of iridovirus diseases, causing fish mortalities and economic losses all over the world. Virus identification based on candidate gene sequencing is faster, more accurate and more reliable than other traditional phenotype methodologies. Iridoviridae viruses are covered by a protein shell (capsid) encoded by the important candidate gene, major capsid protein (MCP). In this study, we investigated the potential of the MCP gene for use in the diagnosis and identification of infections caused Megalocytivirus of the Iridoviridae family. We selected data of 66 Iridoviridae family isolates (53 strains of Megalocytivirus, eight strains of iridoviruses and five strains of Ranavirus) infecting various species of fish distributed all over the world. A total of 53 strains of Megalocytivirus were used for designing the complete primer sets for identifying the most hypervariable region of the MCP gene. Further, our in silico analysis of 102 sequences of related and unrelated viruses reconfirms that primer sets could identify strains more specifically and offers a useful and fast alternative for routine clinical laboratory testing. Our findings suggest that phenotype observation along with diagnosis using universal primer sets can help detect infection or carriers at an early stage.
Collapse
Affiliation(s)
- A Mishra
- Genetic Engineering Institute, Pusan National University, Busan, Korea
| | - G-H Nam
- Genetic Engineering Institute, Pusan National University, Busan, Korea
- Department of Biological Sciences, College of Natural Sciences, Pusan National University, Busan, Korea
| | - J-A Gim
- Department of Biological Sciences, College of Natural Sciences, Pusan National University, Busan, Korea
| | - H-E Lee
- Genetic Engineering Institute, Pusan National University, Busan, Korea
- Department of Biological Sciences, College of Natural Sciences, Pusan National University, Busan, Korea
| | - A Jo
- Genetic Engineering Institute, Pusan National University, Busan, Korea
- Department of Biological Sciences, College of Natural Sciences, Pusan National University, Busan, Korea
| | - D Yoon
- Department of Chemistry, College of Natural Sciences, Pusan National University, Busan, Korea
| | - S Oh
- Department of Chemistry, College of Natural Sciences, Pusan National University, Busan, Korea
| | - S Kim
- Department of Chemistry, College of Natural Sciences, Pusan National University, Busan, Korea
| | - A Kim
- Department of Aquatic Life Medicine, Pukyong National University, Busan, Korea
| | - D-H Kim
- Department of Aquatic Life Medicine, Pukyong National University, Busan, Korea
| | - Y C Kim
- Department of Aquatic Life Medicine, Pukyong National University, Busan, Korea
| | - H D Jeong
- Department of Aquatic Life Medicine, Pukyong National University, Busan, Korea
| | - H-J Cha
- Departments of Parasitology and Genetics, College of Medicine, Kosin University, Busan, Korea
| | - Y H Choi
- Department of Biochemistry, College of Korean Medicine, Dongeui University, Busan, Korea
| | - H-S Kim
- Genetic Engineering Institute, Pusan National University, Busan, Korea
- Department of Biological Sciences, College of Natural Sciences, Pusan National University, Busan, Korea
| |
Collapse
|
10
|
You S, An M, Yoon D, Ban G, Joung B, Park R. P2681Rate-control treatment and clinical outcomes in patients with atrial fibrillation and obstructive lung disease. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p2681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
11
|
Song S, Lee E, Jun H, Lee K, Yoon D. THE EFFECTS OF EMPLOYMENT ON DEPRESSION AMONG OLDER ADULTS: MEDIATING ROLE OF SELF-EESTEEM. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.4476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- S. Song
- Dep. of child and family studies, Yonsei University, Seoul, Korea (the Republic of)
| | - E. Lee
- Dep. of child and family studies, Yonsei University, Seoul, Korea (the Republic of)
| | - H. Jun
- Dep. of child and family studies, Yonsei University, Seoul, Korea (the Republic of)
| | - K. Lee
- Dep. of child and family studies, Yonsei University, Seoul, Korea (the Republic of)
| | - D. Yoon
- Dep. of child and family studies, Yonsei University, Seoul, Korea (the Republic of)
| |
Collapse
|
12
|
Kang J, Hong J, Yoon D, Suh C. CLINICAL FEATURES AND SURVIVAL OUTCOMES ON LYMPHOPLASMACYTIC LYMPHOMA PATIENTS WITH NON-IGM PARAPROTEINEMIA COMPARED WITH IGM PARAPROTEINEMIA IN KOREA. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- J. Kang
- Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Republic of Korea
| | - J. Hong
- Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Republic of Korea
| | - D. Yoon
- Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Republic of Korea
| | - C. Suh
- Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Republic of Korea
| |
Collapse
|
13
|
Di Bernardo A, Millo O, Barbone M, Alpern H, Kalcheim Y, Sassi U, Ott AK, De Fazio D, Yoon D, Amado M, Ferrari AC, Linder J, Robinson JWA. Correction: Corrigendum: p-wave triggered superconductivity in single-layer graphene on an electron-doped oxide superconductor. Nat Commun 2017; 8:14807. [PMID: 28248288 PMCID: PMC5337946 DOI: 10.1038/ncomms14817] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
Nature Communications 8: Article number: 14024 (2017); Published: 19 January 2017; Updated: 1 March 2017 The present address for U. Sassi is incorrect in this Article. This author does not have a present address. The correct full affiliation details for this author are given below: Cambridge Graphene Centre, University of Cambridge, Cambridge CB3 0FA, UK.
Collapse
|
14
|
Di Bernardo A, Millo O, Barbone M, Alpern H, Kalcheim Y, Sassi U, Ott AK, De Fazio D, Yoon D, Amado M, Ferrari AC, Linder J, Robinson JWA. p-wave triggered superconductivity in single-layer graphene on an electron-doped oxide superconductor. Nat Commun 2017; 8:14024. [PMID: 28102222 PMCID: PMC5253682 DOI: 10.1038/ncomms14024] [Citation(s) in RCA: 69] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2016] [Accepted: 11/21/2016] [Indexed: 11/21/2022] Open
Abstract
Electron pairing in the vast majority of superconductors follows the Bardeen-Cooper-Schrieffer theory of superconductivity, which describes the condensation of electrons into pairs with antiparallel spins in a singlet state with an s-wave symmetry. Unconventional superconductivity was predicted in single-layer graphene (SLG), with the electrons pairing with a p-wave or chiral d-wave symmetry, depending on the position of the Fermi energy with respect to the Dirac point. By placing SLG on an electron-doped (non-chiral) d-wave superconductor and performing local scanning tunnelling microscopy and spectroscopy, here we show evidence for a p-wave triggered superconducting density of states in SLG. The realization of unconventional superconductivity in SLG offers an exciting new route for the development of p-wave superconductivity using two-dimensional materials with transition temperatures above 4.2 K.
Collapse
Affiliation(s)
- A. Di Bernardo
- Department of Materials Science and Metallurgy, University of Cambridge, 27 Charles Babbage Road, Cambridge CB3 0FS, UK
| | - O. Millo
- Racah Institute of Physics and the Hebrew University Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Jerusalem 91904, Israel
| | - M. Barbone
- Cambridge Graphene Centre, University of Cambridge, Cambridge CB3 0FA, UK
| | - H. Alpern
- Racah Institute of Physics and the Hebrew University Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Jerusalem 91904, Israel
| | - Y. Kalcheim
- Racah Institute of Physics and the Hebrew University Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Jerusalem 91904, Israel
| | - U. Sassi
- Cambridge Graphene Centre, University of Cambridge, Cambridge CB3 0FA, UK
| | - A. K. Ott
- Cambridge Graphene Centre, University of Cambridge, Cambridge CB3 0FA, UK
| | - D. De Fazio
- Cambridge Graphene Centre, University of Cambridge, Cambridge CB3 0FA, UK
| | - D. Yoon
- Cambridge Graphene Centre, University of Cambridge, Cambridge CB3 0FA, UK
| | - M. Amado
- Department of Materials Science and Metallurgy, University of Cambridge, 27 Charles Babbage Road, Cambridge CB3 0FS, UK
| | - A. C. Ferrari
- Cambridge Graphene Centre, University of Cambridge, Cambridge CB3 0FA, UK
| | - J. Linder
- Department of Physics, Norwegian University of Science and Technology, N-7491 Trondheim, Norway
| | - J. W. A. Robinson
- Department of Materials Science and Metallurgy, University of Cambridge, 27 Charles Babbage Road, Cambridge CB3 0FS, UK
| |
Collapse
|
15
|
|
16
|
Kim S, Suh T, Yoon D, Jung J, Shin H, Kim M. TU-FG-BRB-07: GPU-Based Prompt Gamma Ray Imaging From Boron Neutron Capture Therapy. Med Phys 2016. [DOI: 10.1118/1.4957547] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
17
|
Kim M, Jung J, Yoon D, Shin H, Kim S, Suh T. SU-G-JeP3-09: Tumor Location Prediction Using Natural Respiratory Volume for Respiratory Gated Radiation Therapy (RGRT): System Verification Study. Med Phys 2016. [DOI: 10.1118/1.4957074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
18
|
Shin H, Yoon D, Jung J, Kim M, Suh T. SU-G-JeP4-15: Feasibility Study of Tumor Monitoring Technique Using Prompt Gamma Rays During Antiproton Therapy. Med Phys 2016. [DOI: 10.1118/1.4957125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
19
|
Pourmorteza M, Virk H, Yoon D, Riaz I, Rai A, Rahman Z. P14: DOXYCYCLINE: A RARE CAUSE OF DRUG INDUCED PANCREATITIS. J Investig Med 2016. [DOI: 10.1136/jim-2016-000080.54] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Purpose of StudyDrug-induced pancreatitis (DIP) is a rare clinicopathologic entity. We report a 58-year-old female who developed DIP secondary to administration of doxycycline.Methods UsedA 48 year old female with a history of hypertension presented to the hospital with complains of nausea/vomiting, right upper-quadrant gnawing abdominal pain, 8/10 in intensity with radiation to the back. She denied exacerbating factors, use of alcohol, tobacco and drug. Patient also denied diarrhea, constipation and changes in skin or stool color. On examination patient was hypertensive (155/95) with a heart rate of 102. She had epigastric/right upper quadrant tenderness on superficial palpation, hypoactive bowel sounds without any palpable organs, rebound tenderness or rigidity. Serum lipase was elevated at 2508 IU/L, negative pregnancy and insignificant urinalysis findings. Liver function tests, lipid panel, chemistry panel and hematologic panel were within normal limits. Radiologic investigations with abdominal ultrasound depicted mild proximal dilatation of the common bile duct with smooth tapering of the duct distally indicating status post-cholecystectomy. Contrast enhanced computed tomography scan revealed mild enlargement of the body of the pancreas with adjacent peripancreatic fatty infiltration consistent with acute pancreatitis. Upon further questioning patient explains recent diagnosis (7 days) of tibial orthopedic hardware infection as she was prescribed doxycycline 200 mg twice a day in anticipation of irrigation of infected site. After confirmation, and discontinuation of doxycycline, our patient recovered and has been disease-free for over a month.Summary of ResultsDrug-induced pancreatitis is uncommon etiology of acute pancreatitis, which is responsible for 0.1%–2% of all the acute pancreatitis cases. Among adverse drug reactions, pancreatitis is often-ignored because of the difficulty in implicating a drug as its cause.ConclusionsIn our vastly evolving pharmacotherapy world, DIP should be included in the differential of idiopathic pancreatitis, especially after other common causes have been ruled out.
Collapse
|
20
|
Baik I, Yun C, Yoon D, Shin C. Associations of subjective and objective assessments of snoring, telomere shortening, and a missense mutation in the SCN2B gene in a population-based study. Sleep Med 2015. [DOI: 10.1016/j.sleep.2015.02.195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
21
|
Shin H, Yoon D, Jung J, Kim M, Jang H, Suh T. MO-F-CAMPUS-J-05: Verification for Prompt Gamma Ray Imaging During Proton Boron Fusion Therapy. Med Phys 2015. [DOI: 10.1118/1.4925485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
22
|
Jung J, Yoon D, Shin H, Kim M, Suh T. SU-D-304-07: Application of Proton Boron Fusion Reaction to Radiation Therapy. Med Phys 2015. [DOI: 10.1118/1.4923866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
23
|
Yoon D, Jung J, Shin H, Kim M, Jang H, Suh T. SU-E-T-656: Quantitative Analysis of Proton Boron Fusion Therapy (PBFT) in Various Conditions. Med Phys 2015. [DOI: 10.1118/1.4925019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
24
|
Lee JY, Jun NR, Yoon D, Shin C, Baik I. Association between dietary patterns in the remote past and telomere length. Eur J Clin Nutr 2015; 69:1048-52. [DOI: 10.1038/ejcn.2015.58] [Citation(s) in RCA: 58] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2014] [Revised: 02/23/2015] [Accepted: 03/10/2015] [Indexed: 01/21/2023]
|
25
|
Sheen SS, Park RW, Yoon D, Shin GT, Kim H, Park IW. The Model for End-stage Liver Disease score is potentially a useful predictor of hyperkalemia occurrence among hospitalized angiotensin receptor blocker users. J Clin Pharm Ther 2014; 40:48-54. [PMID: 25328056 DOI: 10.1111/jcpt.12224] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2013] [Accepted: 09/17/2014] [Indexed: 12/28/2022]
Abstract
WHAT IS KNOWN AND OBJECTIVE Angiotensin receptor blockers (ARBs) are medications commonly used for treating conditions such as hypertension. However, ARBs are frequently associated with hyperkalemia, a potentially critical adverse event, in high-risk patients. Although both the liver and the kidney are major elimination routes of ARBs, the relationship between hepatorenal function and ARB-related hyperkalemia has not yet been investigated. The purpose of this study was to evaluate the risk of hyperkalemia, in terms of various hepatorenal functions, for hospitalized patients newly initiated on ARB treatment. METHODS We evaluated ARB-related hyperkalemia in a cohort of 5530 hospitalized patients, who had not previously used ARBs, between 12 April 2004 and 31 May 2012. Hepatorenal function was assessed by the Model for End-stage Liver Disease (MELD) score. Hyperkalemia risk was assessed by hepatorenal function, risks were categorized into the four MELD scoring groups, and the groups were compared with one another. RESULTS AND DISCUSSION The MELD score was significantly different between the hyperkalemic and non-hyperkalemic groups (independent t-test, P < 0.001). The MELD score 10-14, 15-19 and ≥ 20 groups showed higher risks of hyperkalemia than the lowest MELD score group {log-rank test, P < 0.001; multiple Cox proportional hazard model, hazard ratios 1.478 (P = 0.003), 2.285 (P < 0.001) and 3.024 (P < 0.001), respectively}. WHAT IS NEW AND CONCLUSION The MELD score showed a stronger predictive performance for hyperkalemia than either serum creatinine or estimated glomerular filtration rate alone. Furthermore, the MELD score showed good predictive performance for ARB-related hyperkalemia among hospitalized patients. The clinical implications and reasons for these findings merit future investigation.
Collapse
Affiliation(s)
- S S Sheen
- Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, Korea
| | | | | | | | | | | |
Collapse
|
26
|
Jung J, Yoon D, Hong K, Suh T. SU-E-J-104: Single Photon Image From PET with Insertable SPECT Collimator for Boron Neutron Capture Therapy: A Feasibility Study. Med Phys 2014. [DOI: 10.1118/1.4888156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
27
|
Yoon D, Jung J, Suh T. SU-E-J-100: Reconstruction of Prompt Gamma Ray Three Dimensional SPECT Image From Boron Neutron Capture Therapy(BNCT). Med Phys 2014. [DOI: 10.1118/1.4888152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
28
|
Brenner M, Benavides S, Mahon SB, Lee J, Yoon D, Mukai D, Viseroi M, Chan A, Jiang J, Narula N, Azer SM, Alexander C, Boss GR. The vitamin B12 analog cobinamide is an effective hydrogen sulfide antidote in a lethal rabbit model. Clin Toxicol (Phila) 2014; 52:490-7. [PMID: 24716792 DOI: 10.3109/15563650.2014.904045] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
BACKGROUND AND PURPOSE Hydrogen sulfide (H2S) is a highly toxic gas for which no effective antidotes exist. It acts, at least in part, by binding to cytochrome c oxidase, causing cellular asphyxiation and anoxia. We investigated the effects of three different ligand forms of cobinamide, a vitamin B12 analog, to reverse sulfide (NaHS) toxicity. METHODS New Zealand white rabbits received a continuous intravenous (IV) infusion of NaHS (3 mg/min) until expiration or a maximum 270 mg dose. Animals received six different treatments, administered at the time when they developed signs of severe toxicity: Group 1-saline (placebo group, N = 9); Group 2--IV hydroxocobalamin (N = 7); Group 3--IV aquohydroxocobinamide (N = 6); Group 4--IV sulfitocobinamide (N = 6); Group 5--intramuscular (IM) sulfitocobinamide (N = 6); and Group 6-IM dinitrocobinamide (N = 8). Blood was sampled intermittently, and systemic blood pressure and deoxygenated and oxygenated hemoglobin were measured continuously in peripheral muscle and over the brain region; the latter were measured by diffuse optical spectroscopy (DOS) and continuous wave near infrared spectroscopy (CWNIRS). RESULTS Compared with the saline controls, all cobinamide derivatives significantly increased survival time and the amount of NaHS that was tolerated. Aquohydroxocobinamide was most effective (261.5 ± 2.4 mg NaHS tolerated vs. 93.8 ± 6.2 mg in controls, p < 0.0001). Dinitrocobinamide was more effective than sulfitocobinamide. Hydroxocobalamin was not significantly more effective than the saline control. CONCLUSIONS Cobinamide is an effective agent for inhibiting lethal sulfide exposure in this rabbit model. Further studies are needed to determine the optimal dose and form of cobinamide and route of administration.
Collapse
Affiliation(s)
- M Brenner
- Beckman Laser Institute, University of California , Irvine, CA , USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Park IW, Sheen SS, Yoon D, Lee SH, Shin GT, Kim H, Park RW. Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring? J Clin Pharm Ther 2013; 39:61-8. [PMID: 24262001 DOI: 10.1111/jcpt.12109] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2013] [Accepted: 10/14/2013] [Indexed: 12/19/2022]
Abstract
WHAT IS KNOWN AND OBJECTIVE Angiotensin receptor blockers (ARBs) frequently induce hyperkalaemia in high-risk patients. Early detection of hyperkalaemia can reduce the subsequent harmful effects. This study was performed to examine the onset time of hyperkalaemia after ARB therapy. METHODS We carried out a retrospective analysis to determine the onset time of hyperkalaemia (serum potassium >5·5 mm) among hospitalized patients newly starting ARB therapy between 2004 and 2012, in a tertiary teaching hospital. Predefined possible risk factors and concomitant medications were evaluated. RESULTS AND DISCUSSION During the 97-month study period, a total of 4267 hospitalized patients started ARBs as new drugs and 225 patients showed hyperkalaemia. A significantly increased risk of hyperkalaemia was detected among patients with a high baseline potassium [odds ratio (OR) 6·0] and those who took non-potassium-sparing diuretics (OR 2·2) or potassium supplements (OR 1·6). A high glomerular filtration rate (GFR) was associated with a lower risk of hyperkalaemia (OR 0·992). Fifty-two percentage of hyperkalaemic events occurred within the first week after initiation of ARB therapy. The highest frequency of hyperkalaemia occurred on the first day after initiation of ARBs. Hyperkalaemia occurred earlier in patients with a high baseline serum potassium level, reduced GFR, diabetes and in those without heart failure. WHAT IS NEW AND CONCLUSION Hyperkalaemia occurs most frequently at the beginning of ARB therapy in hospitalized patients. Monitoring of serum potassium and estimated GFR after initiation of ARBs should be started within a few days or not later than 1 week, especially in patients with risk factors.
Collapse
Affiliation(s)
- I-W Park
- Department of Nephrology, Ajou University School of Medicine, Suwon, Korea
| | | | | | | | | | | | | |
Collapse
|
30
|
Jung J, Kim M, Yoon D, Suh T. SU-E-T-116: Dosimetry On Beam Modeling at the Small Field for Stereotactic Radiosurgery. Med Phys 2013. [DOI: 10.1118/1.4814551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
31
|
Yoon D, Suh T. SU-E-T-395: MCNPX Simulation of Dosimetry From Grid Tpye Multi-Layer Pixel Collimator for Radiation Therapy Treatment. Med Phys 2013. [DOI: 10.1118/1.4814829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
32
|
Keum M, Hong S, Han H, Yoon D, Seo J, Yun I. Clinical effect of altered lipid emulsion composition containing fish oil in postoperative patients following abdominal surgery: a prospective, randomized, open-label, comparative, multicenter phase 3 clinical study. Crit Care 2013. [PMCID: PMC3642592 DOI: 10.1186/cc12187] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
33
|
Im J, Choi Y, Seong J, Lee I, Park J, Yoon D, Kim K, Lee W. Higher Radiation Dose May Benefit Patients With Extrahepatic Bile Duct Cancer Undergoing Curative Resection. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
34
|
Park MY, Yoon D, Choi NK, Lee J, Lee K, Lim HS, Park BJ, Kim JH, Park RW. Construction of an open-access QT database for detecting the proarrhythmia potential of marketed drugs: ECG-ViEW. Clin Pharmacol Ther 2012; 92:393-6. [PMID: 22828716 DOI: 10.1038/clpt.2012.93] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Information about the QT interval from surface electrocardiograms (ECGs) is essential for surveillance of the proarrhythmia potential of marketed drugs. However, ECG records obtained in daily practice cannot be easily used for this purpose without labor-intensive manual effort. This study was aimed at constructing an open-access QT database, the Electrocardiogram Vigilance with Electronic Data Warehouse (ECG-ViEW). This longitudinal observational database contains 710,369 measurements of QT and associated clinical data from 371,401 patients. The de-identified database is freely available at http://www.ecgview.org.
Collapse
Affiliation(s)
- M Y Park
- Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea
| | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Lee SH, Cho YM, Lim D, Kim HC, Choi BH, Park HS, Kim OH, Kim S, Kim TH, Yoon D, Hong SK. Linkage Disequilibrium and Effective Population Size in Hanwoo Korean Cattle. Asian Australas J Anim Sci 2011. [DOI: 10.5713/ajas.2011.11165] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
36
|
Choi JS, Kim JS, Byun IS, Lee DH, Lee MJ, Park BH, Lee C, Yoon D, Cheong H, Lee KH, Son YW, Park JY, Salmeron M. Friction Anisotropy-Driven Domain Imaging on Exfoliated Monolayer Graphene. Science 2011; 333:607-10. [DOI: 10.1126/science.1207110] [Citation(s) in RCA: 255] [Impact Index Per Article: 19.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
37
|
Lim HT, Kim BW, Yoon D, Lee SH, Yoo CK, Lee JH, Jeon JT. An allelic ladder for eleven short tandem repeat loci for use in the cattle identity test. Anim Genet 2011; 42:226-7. [PMID: 24725233 DOI: 10.1111/j.1365-2052.2010.02142.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- H-T Lim
- Division of Applied Life Science (BK21 Program), Graduate School of Gyeongsang National University, Jinju 660-701, Korea.Division of Animal Genomics and Bioinformatics, National Institute of Animal Science, RDA, Suwon 441-706, Korea.Division of Animal Science and Resources, College of Agriculture and Life Sciences, Chungnam National University, Daejeon 305-764, Korea
| | | | | | | | | | | | | |
Collapse
|
38
|
Yoon D, Ryu M, Park Y, Lee H, Lee C, Lee J, Ryoo B, Chang H, Kim T, Kang Y. Phase II study of everolimus in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.4_suppl.93] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
93 Background: To evaluate feasibility with activity and toxicities of everolimus, a novel inhibitor of mammalian target of rapamycin (mTOR), in patients with advanced gastric cancer (AGC) who failed chemotherapy including both fluoropyrimidine and platinum (FP). Methods: Fifty-four patients were enrolled between Jul 2008 and Feb 2010. Everolimus, 10 mg daily, was given until disease progression or unacceptable toxicity. Primary objective was to determine 4-month progression-free survival (PFS) and secondary objectives were to investigate response rate, toxicity and overall survival OS rate. Pre- (n = 28) and on-treatment (n = 19) tumor biopsies were evaluated for phosphorylated (p) mTOR, pS6 kinase1, pS6 and eukaryotic initiation factor 4E binding protein 1 expression. Results: A total of 180 cycles of everolimus were administered with a median of 2 (range, 1-20) cycles in each patient. Two patients (3.7%) achieved confirmed partial response and 19 patients (35.2%) showed stable disease, resulting in a disease control rate of 38.9%. At a median follow-up duration of 8.7 months in surviving patients (range, 3.0–19.4 months), a 4-month PFS rate was 18.4% with a median PFS of 1.7 months (95% CI, 1.5-2.2 months) and a median OS time was 8.3 months (95% CI, 4.5-12.1 months). Peritoneal metastasis (Hazard ratio [HR], 3.97; 95% CI, 1.54-10.23; p = 0.010) and low expression level of pS6Ser240/4 at baseline (HR, 7.64; 95% CI, 2.591-22.51; p = 0.001) were significantly associated with shorter PFS time. Treatment was in general well tolerated. Toxicities of grade 3/4 included anemia (9.4%), thrombocytopenia (9.4%), hepatic dysfunction (11.3%) and pulmonary toxicities (one interstitial pneumonitis and a diffuse alveolar hemorrhage [DAH] case). The DAH and cardiopulmonary dysfunction in another case resulted in treatment-related mortalities. Conclusions: Everolimus monotherapy showed modest activity against AGC refractory to FP. pS6Ser240/4 might be a potential biomarker for the clinical activity of everolimus. The toxicity profile was generally mild. However, careful monitoring for treatment-related pulmonary complication seems to be required. [Table: see text]
Collapse
Affiliation(s)
- D. Yoon
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - M. Ryu
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Y. Park
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - H. Lee
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - C. Lee
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - J. Lee
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - B. Ryoo
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - H. Chang
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - T. Kim
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Y. Kang
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| |
Collapse
|
39
|
Yoon D, Paek S, Kim S, Kim K, Ahn D. Numerical heat transfer analysis for the design of the engineering-scale electrowinning cell in pyroprocessing. Chem Eng Sci 2010. [DOI: 10.1016/j.ces.2010.05.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
40
|
Ryoo B, Yoon D, Ryu M, Lee S, Hwang S, Suh D, Lee J, Kim T, Chang H, Kang Y. Sorafenib for recurrent hepatocellular carcinoma after liver transplantation. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e14669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
41
|
Ryu M, Yoon D, Ryoo B, Beck M, Choi D, Cho Y, Lee J, Chang H, Kim T, Kang Y. Sunitinib as the second-line therapy for advanced GISTs after failure of imatinib in Korean patients. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.10083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
42
|
Kim S, Yoon D, Cho Y, Nam S, Choi S, Lee S, Lee J, Kim J, Cho K. Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving induction chemotherapy and definitive chemoradiotherapy. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.5524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
43
|
Hoercher K, Smedira N, Yoon D, Rajeswaran J, Blackstone E. 81: Timing of Transplant Following Mechanical Circulatory Support in 375 Patients: Lessons from a Single Center Experience. J Heart Lung Transplant 2010. [DOI: 10.1016/j.healun.2009.11.089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
44
|
Lee SM, Jeong YH, Kim HM, Park HY, Yoon D, Kim DH, Saeki S, Moon SJ, Kang MJ. Presenilin enhancer-2 (PSENEN), a component of the gamma-secretase complex, is involved in adipocyte differentiation. Domest Anim Endocrinol 2009; 37:170-80. [PMID: 19592191 DOI: 10.1016/j.domaniend.2009.05.003] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/12/2009] [Revised: 05/20/2009] [Accepted: 05/23/2009] [Indexed: 11/16/2022]
Abstract
This study was conducted to identify genes expressed during adipocyte differentiation of bovine intramuscular fibroblast-like cells using differential display reverse-transcriptase polymerase chain reaction. The presenilin enhancer-2 (PSENEN) gene was found to be down-regulated during adipocyte differentiation of bovine intramuscular fibroblast-like cells. The ectopic expression of bovine PSENEN in 3T3-L1 reduced adipogenesis and the inhibition of endogenous PSENEN by siRNA induced adipogenesis on d 4 of adipocyte differentiation of 3T3-L1 cells. Interestingly, the expression of gamma-secretase complex gene-related Notch signaling was decreased at d 2 and d 4 during adipocyte differentiation. In addition, expression of the Notch-signaling genes (Notch-1, Hes-1, Pref-1, adipsin) was regulated during adipocyte differentiation by regulation of PSENEN expression. These results suggest that PSENEN plays an important role in adipocyte differentiation and that Notch signaling is involved in adipogenesis.
Collapse
Affiliation(s)
- S M Lee
- Department of Animal Science, College of Agriculture and Life Science, Institute of Agricultural Science and Technology, Chonnam National University, Gwangju 500-757, Korea
| | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Kim J, Kim E, Sohn B, Yoon D, Yoo C, Kim S, Lee D, Kim S, Lee J, Suh C. BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.7097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
7097 Background: The objective of this study was to compare the efficacy and toxicity of two high-dose regimens for autologous stem cell transplantation (ASCT) in patients with non-Hodgkin's lymphoma (NHL): BEAM (BCNU, etoposide, cytarabine, and melphalan) and BuCyE (busulfan, cyclophosphamide, and etoposide). Methods: We analysed 65 NHL patients, who underwent high-dose chemotherapy with BEAM (N=43) or BuCyE (N=22), followed by ASCT, at the Asan Medical Center. BEAM was used from February 2002 to October 2005, and BuCyE was used from November 2005 to April 2008. Results: Median age was 46 years (range: 15–68), and baseline characteristics, such as gender, International Prognostic Index (IPI), age adjusted IPI, stage and status of disease at ASCT, and median number of infused CD 34+cells/kg were well balanced between groups. The incidence of mucositis, nausea/vomiting, diarrhea and bleeding, and the number of events clinically important infections during ASCT did not differ between groups. Median follow-up for survivors was 49.3 months in the BEAM group and 21.5 months in the BuCyE group. Median overall survival (OS) was 30.6 months (95% confidence interval [CI], 8.19–53.0 months) and 22.6 months (95% CI, 12.1–33.1 months) and median event-free survival (EFS) was 16.1 months (95% CI, 0.0–53.6 months) and 11.2 months (95% CI, 0.0–22.5 months) in the BEAM and BuCyE group, respectively. There were no significant differences in OS (p=0.636) and EFS (p=0.575) between the two groups. Conclusions: In our analysis, BuCyE appeared to be not inferior to BEAM for survival. And we found that regimen-related toxicities did not differ significantly between the two groups. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- J. Kim
- Asan Medical Center,University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - E. Kim
- Asan Medical Center,University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - B. Sohn
- Asan Medical Center,University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - D. Yoon
- Asan Medical Center,University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - C. Yoo
- Asan Medical Center,University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - S. Kim
- Asan Medical Center,University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - D. Lee
- Asan Medical Center,University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - S. Kim
- Asan Medical Center,University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - J. Lee
- Asan Medical Center,University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - C. Suh
- Asan Medical Center,University of Ulsan College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
46
|
Yoon D, Sohn B, Kim J, Yoo C, Kim S, Lee D, Kim S, Huh J, Lee J, Suh C. The role of prophylactic antimicrobials during autologous stem cell transplantation: A single center experience. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.7105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
7105 Background: The aim of this retrospective study was to investigate the efficacy of antibiotic prophylaxis during autologous peripheral stem cell transplantation (ASCT) in patients with multiple myeloma (MM) and non-Hodgkin's lymphoma (NHL). Methods: We searched Asan Medical Center Registry for NHL and MM: Total 114 cases received antimicrobial prophylaxis; while 118 cases did not receive antimicrobial prophylaxis during ASCT. Results: In prophylaxis group, 80 of 114 (70.2%) patients had experienced febrile episodes at median day +6 after transplantation with a statistically significant difference (P<0.001). In no-prophylaxis group, 111 of 118 (94.1%) patients had experienced at median day +5. Documented infection occurred in 14 of 114 (12.3%) patients in prophylaxis group, and 16 of 118 (13.6%) patients in no-prophylaxis group (P=0.846). In these patients, the positive blood culture was seen in 12 (10.5%) of 114 patients in prophylaxis group, and 12 (10.7%) of 118 patients in no-prophylaxis group (P=1.000). Documented viral infection or reactivation was not observed in prophylaxis group, but observed in 4 patients of no-prophylaxis group. Both groups showed no invasive fungal infection or serious adverse event during ASCT. The day of infection resolved was a median day +15 (range, 3–29) in prophylaxis group and day +14 (range, 2–70) in no-prophylaxis group (P=0.945). The duration of antimicrobial treatment was median 10 days both in prophylaxis group and in no-prophylaxis group (P=0.565). Conclusions: In our experience, the antimicrobial prophylaxis seems to decrease the incidence of febrile episodes during ASCT, but seems to have no beneficial effect on reducing infectious complications. The antimicrobial prophylaxis of our study did not show the difference in the detection of causative organism as an infective agent, duration of antimicrobial therapy and hospitalization between two groups. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- D. Yoon
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - B. Sohn
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - J. Kim
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - C. Yoo
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - S. Kim
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - D. Lee
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - S. Kim
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - J. Huh
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - J. Lee
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - C. Suh
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
47
|
Yoo C, Sohn B, Kim J, Yoon D, Huh J, Kim S, Lee D, Kim S, Lee J, Suh C. The prognostic significance of the number of extranodal sites in the patients with disseminated diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.8570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
8570 Background: The combination of rituximab and CHOP chemotherapy (R-CHOP) has improved survival of patients with diffuse large B-cell lymphoma (DLBCL). Recently, several reports have shown that standard International Prognostic Index (IPI) became less powerful prognostic predictor in patients with DLBCL in the era of R-CHOP. We evaluated the prognostic factors of DLBCL patients treated with R-CHOP. Detailed analysis was planned regarding the number of extranodal sites because of its higher frequency in Korea. Methods: Between January 2002 and May 2008, 126 patients with stage III/IV DLBCL treated with R-CHOP were identified. We performed the retrospective analysis of the clinicopathologic factors and verified the predictive power of standard IPI and revised IPI (R-IPI) which was reported by the study group of British Columbia. Various numbers of extranodal sites were analyzed for further stratification and we set E-IPI as the IPI when the number of extranodal sites is stratified in ≤2 vs >2. Results: In the univariate analysis, the number of extranodal sites (≤2 vs >2) was a significant prognostic factor for complete response (CR) (p=0.04), event-free survival (EFS) (p=0.01) and overall survival (OS) (p<0.001). Age was also significant for EFS (p=0.03). When the number of extranodal site was stratified differently (0 vs >0, or ≤1 vs >1), these were not associated with CR, EFS and OS. On the multivariate analysis, the number of extranodal sites (≤2 vs >2) remained significant for EFS (p<0.01, HR 2.6) and OS (p<0.01, HR 3.5). The standard IPI identified 3 risk groups with 2-year EFS; 68%, 55%, 56% (p=0.17) and 2-year OS; 85%, 68%, 58%, respectively (p=0.04). The R-IPI classified 2 risk groups with 2-year EFS; 65%, 50% (p=0.02) and 2-year OS 76%, 62%, respectively (p=0.04). The E-IPI represented 3 risk groups with 2-year EFS; 79%, 56%, 42% (p=0.01) and 2-year OS; 86%, 70%, 39%, respectively (p=0.001). The patient group with survival of less than 50% was only recognized by E-IPI. Conclusions: The number of extranodal sites (≤2 vs >2) is the most significant prognostic factor of EFS and OS. Although all three indices remain predictive, E-IPI is the best model to identify the prognostic group in this cohort with stage III/IV DLBCL treated with R-CHOP. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- C. Yoo
- Asan Medical Center, Seoul, Republic of Korea
| | - B. Sohn
- Asan Medical Center, Seoul, Republic of Korea
| | - J. Kim
- Asan Medical Center, Seoul, Republic of Korea
| | - D. Yoon
- Asan Medical Center, Seoul, Republic of Korea
| | - J. Huh
- Asan Medical Center, Seoul, Republic of Korea
| | - S. Kim
- Asan Medical Center, Seoul, Republic of Korea
| | - D. Lee
- Asan Medical Center, Seoul, Republic of Korea
| | - S. Kim
- Asan Medical Center, Seoul, Republic of Korea
| | - J. Lee
- Asan Medical Center, Seoul, Republic of Korea
| | - C. Suh
- Asan Medical Center, Seoul, Republic of Korea
| |
Collapse
|
48
|
Sohn B, Yoon D, Kim S, Lee D, Kim S, Huh J, Lee J, Suh C. Outcomes in patients with primary gastric diffuse large B-cell lymphoma after rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) chemotherapy. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e19543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e19543 Background: The optimal therapy for primary gastric diffuse large B- cell lymphoma (DLBCL) still needs to be defined. The aim of this study was to investigate the patient's outcomes after rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) treatment in primary gastric DLBCL in a single institution. Methods: We searched AMC Registry for Non-Hodgkin's Lymphoma and found 26 patients with primary gastric DLBCL, who received R-CHOP as first-line chemotherapy. Ten of 26 patients had localized disease. Remaining patients had disseminated disease. R-CHOP was repeated every 21 days in all patients. Results: Overall, complete response (CR) was observed in 20 of 26 patients (76.9%). Three-year event free survival (EFS) and overall survival (OS) was 76.5% and 75.0%, respectively. After analyses of 10 patients with localized disease, we found that these patients had received a total 38 cycles, with a median of 3 cycles per patient. Of 10 patients, one patient had 2 cycles of R-CHOP, 4 had 3 cycles, and one had 4 cycles, all 6 patients above followed by consolidation radiotherapy. Remaining one patient and 4 patients had 5 cycles and 6 cycles of R-CHOP, respectively. In patients with localized disease, CR was observed in 10 of 10 patients (100%), and both 3-year EFS and OS was 100% (10 of 10 patients). In analyses with 16 patients with disseminated disease, all patients had received a total 91 cycles, with a median of 6 cycles per patient. In these patients, two patients had radiation therapy after R-CHOP, one patient had CR before consolidation radiation therapy, and another had partial response before radiation therapy. CR after R-CHOP treatment was observed in 10 of 16 patients (62.5%), partial response in 3 patients, stable disease in 1 patient, and progressive disease in 1 patient. Three-year EFS and OS was 61.1% and 57.8% in patients with disseminated disease. Conclusions: R-CHOP regimen showed a promising result in primary gastric DLBCL. Combination with rituximab in CHOP regimen showed excellent prognosis especially in patients with localized disease. In localized disease, CR was 100%, 3-year EFS and OS was 100%. In disseminated disease, CR was 62.5%, 3-year EFS and OS was 61.1% and 57.8%. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- B. Sohn
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - D. Yoon
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - S. Kim
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - D. Lee
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - S. Kim
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - J. Huh
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - J. Lee
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - C. Suh
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
49
|
Bhuiyan MSA, Yu SL, Jeon JT, Yoon D, Cho YM, Park EW, Kim NK, Kim KS, Lee JH. DNA Polymorphisms in SREBF1 and FASN Genes Affect Fatty Acid Composition in Korean Cattle (Hanwoo). Asian Australas J Anim Sci 2009. [DOI: 10.5713/ajas.2009.80573] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
50
|
Yoon D, Kwon YS, Lee KY, Jung WY, Sasazaki S, Mannen H, Jeon JT, Lee JH. Discrimination of Korean Cattle (Hanwoo) Using DNA Markers Derived from SNPs in Bovine Mitochondrial and SRY Genes. Asian Australas J Anim Sci 2008. [DOI: 10.5713/ajas.2008.70209] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|